Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
44.59
+0.04 (0.09%)
Jul 21, 2026, 9:52 AM EDT - Market open
Astrana Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,007 | 1,213 | 1,511 | 1,794 | 1,378 | 3,279 | |
Market Cap Growth | 58.09% | -19.74% | -15.77% | 30.18% | -57.98% | 324.86% |
Enterprise Value | 2,592 | 1,641 | 1,495 | 1,615 | 1,330 | 3,256 |
Last Close Price | 44.59 | 24.81 | 31.53 | 38.30 | 29.59 | 73.48 |
PE Ratio | 73.22 | 53.93 | 35.03 | 29.69 | 29.89 | 48.34 |
Forward PE | 30.34 | 29.95 | 25.02 | 30.62 | 65.76 | 63.35 |
PEG Ratio | 0.37 | 0.89 | 1.36 | 2.14 | 1.49 | 2.50 |
PS Ratio | 0.57 | 0.38 | 0.74 | 1.29 | 1.20 | 4.24 |
PB Ratio | 2.72 | 1.56 | 2.12 | 2.92 | 2.54 | 7.32 |
P/TBV Ratio | - | - | 8.63 | 6.82 | 6.86 | 28.05 |
P/FCF Ratio | 12.94 | 11.61 | 34.22 | 45.19 | 23.28 | 64.16 |
P/OCF Ratio | 12.08 | 10.58 | 28.95 | 26.30 | 16.78 | 46.63 |
EV/Sales Ratio | 0.74 | 0.52 | 0.73 | 1.16 | 1.16 | 4.21 |
EV/EBITDA Ratio | 16.24 | 13.20 | 12.75 | 15.78 | 10.92 | 28.15 |
EV/EBIT Ratio | 24.63 | 20.89 | 16.73 | 19.09 | 12.76 | 33.17 |
EV/FCF Ratio | 16.73 | 15.70 | 33.85 | 40.69 | 22.47 | 63.71 |
Debt / Equity Ratio | 1.75 | 1.83 | 0.89 | 0.72 | 0.40 | 0.39 |
Debt / EBITDA Ratio | 7.56 | 8.68 | 4.01 | 3.14 | 1.88 | 1.74 |
Debt / FCF Ratio | 6.87 | 10.32 | 10.66 | 8.09 | 3.88 | 3.93 |
Net Debt / Equity Ratio | 0.73 | 0.83 | 0.26 | 0.04 | -0.12 | -0.19 |
Net Debt / EBITDA Ratio | 4.17 | 5.22 | 1.55 | 0.24 | -0.53 | -0.74 |
Net Debt / FCF Ratio | 3.79 | 6.21 | 4.13 | 0.62 | -1.08 | -1.67 |
Asset Turnover | 1.54 | 1.78 | 1.78 | 1.46 | 1.25 | 0.92 |
Quick Ratio | 1.31 | 1.36 | 1.68 | 2.03 | 2.78 | 3.36 |
Current Ratio | 1.35 | 1.40 | 1.75 | 2.11 | 2.88 | 3.53 |
Return on Equity (ROE) | 5.46% | 4.49% | 10.80% | 11.94% | 8.56% | 9.64% |
Return on Assets (ROA) | 2.36% | 2.67% | 4.82% | 5.74% | 6.01% | 6.90% |
Return on Invested Capital (ROIC) | 4.55% | 5.02% | 9.75% | 11.72% | 11.98% | 13.38% |
Return on Capital Employed (ROCE) | 5.38% | 6.06% | 10.49% | 11.04% | 13.28% | 13.49% |
Earnings Yield | 1.51% | 1.85% | 2.85% | 3.37% | 3.35% | 2.07% |
FCF Yield | 7.73% | 8.62% | 2.92% | 2.21% | 4.29% | 1.56% |
Dividend Yield | - | 0.65% | 0.27% | 3.48% | 1.05% | 0.97% |
Payout Ratio | - | 35.06% | 9.35% | 102.24% | 31.06% | 45.11% |
Buyback Yield / Dilution | -2.40% | -2.91% | -2.20% | -2.94% | -0.44% | -21.24% |
Total Shareholder Return | -2.40% | -2.26% | -1.93% | 0.54% | 0.62% | -20.28% |